Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Lipoic acid

Generic Name: Lipoic acid

Drug Type: Small Molecule

Chemical Formula: C_₈H_₁₄O_₂S_₂

CAS Number: 1200-22-2

Unique Ingredient Identifier: VLL71EBS9Z

Overview

A vitamin-like antioxidant.

Background

A vitamin-like antioxidant.

Indication

For nutritional supplementation, also for treating dietary shortage or imbalance.

Associated Conditions

Diabetic Neuropathies
Type 2 Diabetes Mellitus

Clinical Trials

Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects

Not Applicable

Completed

Posted: 2025/03/25

Sponsor:University of Messin...

ID:NCT06787781

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

Phase 2

Recruiting

Posted: 2024/11/25

Sponsor:British University I...

ID:NCT06703593

Effect of ALA Combined with Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females

Phase 3

Recruiting

Posted: 2024/05/17

Sponsor:Ain Shams University

ID:NCT06418347

Alpha Lipoic Acid in Pediatrics on Hemodialysis

Phase 3

Posted: 2024/02/29

Sponsor:Ain Shams University

ID:NCT06286098

Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)

Not Applicable

Completed

Posted: 2024/01/08

Sponsor:

Lu Jiang

ID:NCT06195137

FDA Approved Products

Vita-Rx Diabetic Vitamin

Manufacturer:Pure Source, LLC

Route:ORAL

Strength:150 mg in 1 1

Approved: 2023/11/22

NDC:65121-301

Strovite One Caplets

Manufacturer:Exeltis USA, Inc.

Route:ORAL

Strength:15 mg in 1 1

Approved: 2023/01/02

NDC:0642-0207

Vita-Rx Diabetic Vitamin

Manufacturer:MAS Management Group Inc.

Route:ORAL

Strength:150 mg in 1 1

Approved: 2015/08/11

NDC:69677-050

Bio Co Enzyme Phase

Manufacturer:Deseret Biologicals, Inc.

Route:ORAL

Strength:8 [hp_X] in 1 mL

Approved: 2025/04/08

NDC:43742-2259

Energize

Manufacturer:Parasitology Center Inc.

Route:ORAL

Strength:8 [hp_X] in 1 mL

Approved: 2025/05/22

NDC:70321-0003

Singapore Approved Products

No Singapore products found for this drug

Related News

World-First Octopus Trial Offers New Hope for Progressive Multiple Sclerosis Patients

a day ago

The innovative Octopus trial represents the world's first multi-armed, multi-staged clinical study specifically designed to test multiple potential treatments for progressive multiple sclerosis simultaneously.

Topiramate and Pregabalin Reduce Migraine Frequency and Intensity in Pediatric Patients

7 months ago

A network meta-analysis reveals that pregabalin and topiramate, with or without vitamin D3, significantly reduce migraine frequency in children and adolescents.

OCTOPUS Trial Shows Progress in Evaluating Alpha-Lipoic Acid and Metformin for Progressive MS

8 months ago

The OCTOPUS trial, a multi-arm study, is assessing R/S alpha-lipoic acid and metformin for progressive multiple sclerosis, aiming to enroll 375 participants in its first stage.

Extended-Course Nirmatrelvir/Ritonavir Shows Promise in Treating Long COVID Symptoms

2 years ago

A series of case studies highlights the potential benefits of extended-course nirmatrelvir/ritonavir treatment for individuals suffering from Long COVID, with some patients reporting significant improvements in symptoms. The treatment, typically used for acute COVID-19 infections, was administered outside of the acute phase, offering new insights into managing Long COVID.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy